These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Efficacy and Safety of Ixekizumab in the Treatment of Radiographic Axial Spondyloarthritis: Sixteen-Week Results From a Phase III Randomized, Double-Blind, Placebo-Controlled Trial in Patients With Prior Inadequate Response to or Intolerance of Tumor Necrosis Factor Inhibitors. Deodhar A, Poddubnyy D, Pacheco-Tena C, Salvarani C, Lespessailles E, Rahman P, Järvinen P, Sanchez-Burson J, Gaffney K, Lee EB, Krishnan E, Santisteban S, Li X, Zhao F, Carlier H, Reveille JD, COAST-W Study Group. Arthritis Rheumatol; 2019 Apr; 71(4):599-611. PubMed ID: 30343531 [Abstract] [Full Text] [Related]
25. Procollagen I N-terminal peptide correlates with inflammation on sacroiliac joint magnetic resonance imaging in ankylosing spondylitis but not in non-radiographic axial spondyloarthritis: A cross-sectional study. Li X, Liang A, Chen Y, Lam NS, Long X, Xu X, Zhong S. Mod Rheumatol; 2022 Jul 01; 32(4):770-775. PubMed ID: 34897520 [Abstract] [Full Text] [Related]
27. Scoring magnetic resonance imaging (MRI) inflammation and structural lesions in sacroiliac joints of patients with axial spondyloarthritis: assessment of all MRI slices of the cartilaginous compartment versus standardized six or five slices. Krabbe S, Kröber G, Pedersen SJ, Østergaard M, Møller JM, Sørensen IJ, Jensen B, Madsen OR, Klarlund M, Weber U. Scand J Rheumatol; 2020 May 01; 49(3):200-209. PubMed ID: 31847676 [Abstract] [Full Text] [Related]
29. Limited radiographic progression and sustained reductions in MRI inflammation in patients with axial spondyloarthritis: 4-year imaging outcomes from the RAPID-axSpA phase III randomised trial. van der Heijde D, Baraliakos X, Hermann KA, Landewé RBM, Machado PM, Maksymowych WP, Davies OR, de Peyrecave N, Hoepken B, Bauer L, Nurminen T, Braun J. Ann Rheum Dis; 2018 May 01; 77(5):699-705. PubMed ID: 29343510 [Abstract] [Full Text] [Related]
32. Changes over time in inflammatory and structural lesions at the sacroiliac joint in children with spondyloarthritis exposed and unexposed to tumor necrosis factor inhibitor. Brandon TG, Xiao R, Peterson RG, Chauvin NA, Francavilla ML, Biko DM, Rumsey DG, Stoll ML, Weiss PF. Pediatr Rheumatol Online J; 2021 Dec 02; 19(1):167. PubMed ID: 34857002 [Abstract] [Full Text] [Related]
33. Progression of Structural Damage in the Sacroiliac Joints in Patients With Early Axial Spondyloarthritis During Long-Term Anti-Tumor Necrosis Factor Treatment: Six-Year Results of Continuous Treatment With Etanercept. Rios Rodriguez V, Hermann KG, Weiß A, Listing J, Haibel H, Althoff C, Proft F, Behmer O, Sieper J, Poddubnyy D. Arthritis Rheumatol; 2019 May 02; 71(5):722-728. PubMed ID: 30625261 [Abstract] [Full Text] [Related]
34. Ixekizumab improves sleep and work productivity in patients with non-radiographic axial spondyloarthritis: results from the COAST-X trial at 52 weeks. Deodhar A, Mease P, Marzo-Ortega H, Hunter T, Sandoval D, Kronbergs A, Lauzon S, Leung A, Navarro-Compán V. BMC Rheumatol; 2021 Sep 25; 5(1):50. PubMed ID: 34560906 [Abstract] [Full Text] [Related]
36. Relationship between sex and clinical and imaging features of early axial spondyloarthritis: results from a 48 month follow-up (Italian arm of the SPondyloArthritis Caught Early (SPACE) study). Lorenzin M, Cozzi G, Scagnellato L, Ortolan A, Vio S, Striani G, Scapin V, De Conti G, Doria A, Ramonda R. Scand J Rheumatol; 2023 Sep 25; 52(5):519-529. PubMed ID: 36847124 [Abstract] [Full Text] [Related]
38. Structural progression rate decreases over time on serial radiography and magnetic resonance imaging of sacroiliac joints and spine in a five-year follow-up study of patients with ankylosing spondylitis treated with tumour necrosis factor inhibitor. Pedersen SJ, Weber U, Said-Nahal R, Sørensen IJ, Loft AG, Kollerup G, Juul L, Frandsen PB, Thamsborg G, Madsen OR, Møller J, Balding L, Jurik AG, Østergaard M. Scand J Rheumatol; 2019 May 25; 48(3):185-197. PubMed ID: 30422733 [Abstract] [Full Text] [Related]